In silico medicine in the COVID-19 crisis (Part 1)
Five years on from COVID-19, we revisit how in silico models helped detect outbreaks, track transmission, and guide health policies.
Enabling the Digital Revolution of Health
The society for in silico medicine
VPH is an international community driving the adoption of in silico medicine by connecting scientists, industry, clinicians, patients, healthcare providers, regulators, and policymakers for a better and more efficient healthcare.
-
25
Countries involved
-
40+
Institutions involved
-
1000+
Members
By combining computer models, AI, and big data, it helps us better understand diseases, simulate treatments, and predict outcomes. Healthcare is going to be more precise, preventive, and accessible.
For everyone.
-
What is in silico medicine?
Discover more -
What is the VPH Society?
Discover more -
What do we do?
Discover more
News & Events
-
Discover more
-
Decoding multiple sclerosis with in silico medicine
In silico medicine is unlocking breakthroughs in Multiple Sclerosis, bringing new hope to patients. Discover how...
Discover more -
In silico medicine in the COVID-19 crisis (Part 2)
How models allowed to speed up COVID-19 research—optimising vaccines, testing therapies, and simulating immune responses.
Discover more